Next-Gen Nanomedicine for Breast Cancer: From Bench to Bedside and Beyond

##plugins.pubIds.doi.readerDisplayName## https://doi.org/10.70593/978-93-7185-537-2

Authors

Rahul Pal (ed)
Department of Pharmacy, Jagannath University, Jaipur, 303901, Rajasthan, India
https://orcid.org/0000-0003-2062-2678
Binita Ghosh (ed)
Department of Pharmacy Practice, Chitkara College of Pharmacy, Chitkara University, Rajpura, Punjab, India
https://orcid.org/0009-0009-1034-1486
Manju Koli (ed)
Department of Pharmacy, Invertis Institute of Pharmacy, Invertis University, Bareilly, UP, India
https://orcid.org/0000-0001-9836-4539
Prottay Dutta (ed)
Department of Pharmaceutical Chemistry, Usha Martin University, Ranchi, Jharkhand, 835103, India
https://orcid.org/0000-0001-8405-3289

Keywords:

Breast Cancer, Nanomedicine, Targeted Drug Delivery, Nanoparticles, Theranostics, Tumor Microenvironment (TME), Precision Oncology

Synopsis

It is with immense pride and gratitude that I present this edited volume, “Next-Gen Nanomedicine for Breast Cancer: From Bench to Bedside and Beyond.” This book brings together the collective efforts of researchers, clinicians, and academicians working at the interface of nanotechnology and oncology, aiming to illuminate the path toward more effective, targeted, and patient-friendly therapeutic strategies for breast cancer.

The vision behind this book has always been to bridge the gap between fundamental research and clinical application. Nanomedicine has emerged as one of the most promising frontiers in modern science, and its role in revolutionizing breast cancer management cannot be overstated. Each chapter reflects the dedication and insight of experts in the field, offering readers not only cutting-edge scientific knowledge but also a glimpse into the future of personalized medicine.

Chapters

References

Afzal, M., Alharbi, K. S., Alruwaili, N. K., Al-Abassi, F. A., Al-Malki, A. A. L., Kazmi, I., ... & Anwar, F. (2021, February). Nanomedicine in treatment of breast cancer–A challenge to conventional therapy. In Seminars in cancer biology (Vol. 69, pp. 279-292). Academic Press.

Ahmad, M. Z., Alasiri, A. S., Alasmary, M. Y., Abdullah, M. M., Ahmad, J., Abdel Wahab, B. A., ... & Gogoi, U. (2022). Emerging advances in nanomedicine for breast cancer immunotherapy: Opportunities and challenges. Immunotherapy, 14(12), 957-983.

Alibakhshi, A., Kahaki, F. A., Ahangarzadeh, S., Yaghoobi, H., Yarian, F., Arezumand, R., ... & de la Guardia, M. (2017). Targeted cancer therapy through antibody fragments-decorated nanomedicines. Journal of Controlled Release, 268, 323-334.

Banthia, P., Gambhir, L., Sharma, A., Daga, D., Kapoor, N., Chaudhary, R., & Sharma, G. (2022). Nano to rescue: repository of nanocarriers for targeted drug delivery to curb breast cancer. 3 Biotech, 12(3), 70.

Bergin, A. R., & Loi, S. (2019). Triple-negative breast cancer: recent treatment advances. F1000Research, 8, F1000-Faculty.

Bharali, D. J., Khalil, M., Gurbuz, M., Simone, T. M., & Mousa, S. A. (2009). Nanoparticles and cancer therapy: a concise review with emphasis on dendrimers. International journal of nanomedicine, 1-7.

Boyages, J. (2017). Radiation therapy and early breast cancer: current controversies. The Medical Journal of Australia, 207(5), 216-222.

Boix-Montesinos, P., Soriano-Teruel, P. M., Arminan, A., Orzaez, M., & Vicent, M. J. (2021). The past, present, and future of breast cancer models for nanomedicine development. Advanced drug delivery reviews, 173, 306-330.

Bredin, P., Walshe, J. M., & Denduluri, N. (2020, October). Systemic therapy for metastatic HER2-positive breast cancer. In Seminars in oncology (Vol. 47, No. 5, pp. 259-269). WB Saunders.

Candido, N. M., De Melo, M. T., Franchi, L. P., Primo, F. L., Tedesco, A. C., Rahal, P., & Calmon, M. F. (2018). Combining photodynamic therapy and chemotherapy: improving breast cancer treatment with nanotechnology. Journal of Biomedical Nanotechnology, 14(5), 994-1008.

Downloads

Front Pages

Published

9 September 2025
Copyright (c) 2025 Rahul Pal; Bipasha Pal, Mohankumar Ramar, Ramit Rahaman, N. Jawahar, Dharmendra Prasad Kewat, Aditya Soni, Roshan Sonwani, Bharti Gajbe, Rameshroo Kenwat, Vijay Kumar Singh, Disha Bhattacharya, Supriya Saha, Abimanyu Sugumaran, Doneparthi Mihir Medhansh, Pritam Kayal, Susovan Borat; Binita Ghosh, Manju Koli, Prottay Dutta; Arushi, Anjana Devi, Ayushi, Subhanshi Vishwas, Vasanth S, Mythili S R, Akilan A, Priyadharshini N, Deepa V C, Habibur Rahman S M, Natarajan Jawahar, Gopi Patel, Margi Patel, Devang Tandel, Jagruti Vasava, Anshika Garg, Shailendra Kumar, Tharun M, Shivani Sharma, Himanshu Singh, Anuradha Verma, Susanta Kumar Sahu, Nihar Ranjan Das, Ganesh Patro, Bimalendu Chowdhury, Amit Kundu, Shujauddin Ahmed, Agilandeswari Devarajan, Supriya Mana, Vijayanandhan V, Rashmi P, Sahana HD, Mutthuraj Dasegowda, Kanthesh M Basalingappa, Sonia Vatta

Details about the available publication format: E-Book

E-Book

ISBN-13 (15)

978-93-7185-537-2

Details about the available publication format: Book (Paperback)

Book (Paperback)

ISBN-13 (15)

978-93-7185-714-7

How to Cite

Pal, R. ., Ghosh, B. ., Koli, M. ., & Dutta, P. . (Eds.). (2025). Next-Gen Nanomedicine for Breast Cancer: From Bench to Bedside and Beyond. Deep Science Publishing. https://doi.org/10.70593/978-93-7185-537-2
Download Citation